|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/496 | (2006.01) |
| A61K 31/496 | (2013.01) | ||
| A61P 35/02 | (2006.01) | ||
| A61P 35/02 | (2018.01) |
| (11) | Number of the document | 3488850 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17833256.5 |
| Date of filing the European patent application | 2017-04-20 | |
| (97) | Date of publication of the European application | 2019-05-29 |
| (45) | Date of publication and mention of the grant of the patent | 2024-06-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CN2017/081173 |
| Date | 2017-04-20 |
| (87) | Number | WO 2018/018950 |
| Date | 2018-02-01 |
| (30) | Number | Date | Country code |
| 201610592371 | 2016-07-25 | CN | |
| 201611040298 | 2016-11-11 | CN |
| (72) |
LI, Peng , CN
YE, Wei , CN
DING, Ke , CN
LU, Xiaoyun , CN
|
| (73) |
HEALTHQUEST PHARMA INC. ,
Room 314 Building F The South China Center
For Innovative Pharmaceuticals
No. 3 Lanyue Road
Guangzhou Science City, Guangzhou, Guangdong 510530,
CN
|
| (54) | NOVEL APPLICATION OF GZD824 AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF IN TREATING DISEASES |
| NOVEL APPLICATION OF GZD824 AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF IN TREATING DISEASES |